Axa
SPNC

Axa’s Spectranetics Corp SPNC Stock Holding History

Axa’s Portfolio SPNC Stock Details SPNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-255,502
Closed -$3.85M – 1490
2015
Q4 		$3.85M Sell
255,502
-2,268
-0.9% -$29.9K 0.02% 630
2015
Q3 		$3.04M Buy
257,770
+7,101
+3% +$127K 0.01% 692
2015
Q2 		$5.77M Buy
250,669
+2,807
+1% +$78.4K 0.02% 560
2015
Q1 		$8.62M Buy
247,862
+3,797
+2% +$129K 0.04% 433
2014
Q4 		$8.44M Buy
244,065
+783
+0.3% +$24.4K 0.03% 430
2014
Q3 		$6.46M Buy
243,282
+4,549
+2% +$122K 0.03% 479
2014
Q2 		$5.46M Buy
238,733
+47,536
+25% +$1.1M 0.02% 520
2014
Q1 		$5.79M Buy
191,197
+6,196
+3% +$170K 0.03% 495
2013
Q4 		$4.63M Buy
185,001
+4,526
+3% +$97K 0.02% 541
2013
Q3 		$3.03M Buy
180,475
+663
+0.4% +$11.6K 0.01% 647
2013
Q2 		$3.36M Buy
+179,812
New +$3.4M 0.02% 571

Other funds holding SPNC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Axa's SPNC Position: Q1 2016 in Review

Axa sold out of Spectranetics Corp (SPNC) in Q1 2016, closing a stake of 255,502 shares — an estimated $3.85M sold.

Axa first reported a position in SPNC in Q2 2013 and held it in 11 quarters. The position peaked at $8.62M in Q1 2015. 128 funds tracked by Wall St. Rank hold SPNC as of Q1 2016.

  • Axa reported no remaining Spectranetics Corp position as of Q1 2016 after selling out during the quarter.
  • Axa sold 255,502 Spectranetics Corp shares in Q1 2016, an estimated $3.85M.
  • Axa first reported a position in Spectranetics Corp in Q2 2013 and held it in 11 quarters.
  • Axa's Spectranetics Corp position peaked at $8.62M in Q1 2015.
  • 128 funds tracked by Wall St. Rank held Spectranetics Corp as of Q1 2016.

Based on Axa's 13F filing for Q1 2016, filed 13 May 2016.